Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | PRAKASH MEDICOS | Awarded | 1 | ₹2.9 L |
| 2 | Schedule 2 | ALBINO LIFESCIENCES PRIVATE LIMITEDLikely | Evaluation in Progress | 1 | ₹23.1 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
15 Jul 2025, 12:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tab Daralutamide 300mg
Avelumab 200mg Inj
7942847
GEM/2025/B/6323174
Two Packet Bid
Tab Daralutamide 300mg
15 days
Delhi; Central Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
10%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Tab Daralutamide 300mg | Central Delhi | 120 | 15 days | |
| Avelumab 200mg Inj | Central Delhi | 32 | 15 days |
Exempted
15 Jul 2025
23 Jun 2025
15 Jul 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7942847.pdf
GEM_BID
list_of_medicines_02_2025-06-09-10-07-37_8ed433a39860122da529d160773c76d6.pdf
SPECIFICATION
list_of_medicines_02_2025-06-09-10-09-05_eea6b6d587ed7e4a8656f9b4f2bdec9b.pdf
SPECIFICATION
newatc_3bc87bfd-a841-434c-96d11749447873005_shirma.186n@nic.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .